A novel scoring system for prognostic prediction in d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure BALB/c mice

BMC Gastroenterology

Volumn 9, Issue , 2009, Pages

  Feng, Bo ^a   Wu, Sheng M ^b   Lv, Sa ^a   Liu, Feng ^a   Chen, Hong S ^a   Gao, Yan ^a   Dong, Fang T ^b   Wei, Lai ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b National Center of Biomedical Analysis   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; GALACTOSAMINE; GLUCOSE; LACTIC ACID; LIPOPOLYSACCHARIDE; PHOSPHATE; UREA; BIOLOGICAL MARKER; RIBITOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; FULMINANT LIVER FAILURE; GAS CHROMATOGRAPHY; LIVER FAILURE; LIVER INJURY; MALE; METABOLOMICS; MOUSE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONHUMAN; PLASMA; PREDICTION; PROGNOSIS; SCORING SYSTEM; SURVIVAL; TIME OF FLIGHT MASS SPECTROMETRY; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; METHODOLOGY; PREDICTION AND FORECASTING; STATISTICAL MODEL;

3-HYDROXYBUTYRIC ACID; ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; GALACTOSAMINE; LIPOPOLYSACCHARIDES; LIVER FAILURE, ACUTE; LOGISTIC MODELS; MALE; METABOLOMICS; MICE; MICE, INBRED BALB C; MODELS, STATISTICAL; PHOSPHATES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RIBITOL; UREA;

EID: 74549145500     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-9-99     Document Type: Article

References (18)

1. Shakil AO, Mazariegos GV, Kramer DJ. Fulminant hepatic failure. Surg Clin North Am 1999, 79:77-108. 10.1016/S0039-6109(05)70008-6, 10073183.
2. Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology 2005, 41:1179-1197. 10.1002/hep.20703, 15841455.
3. Barba I, Chatauret N, Garcia-Dorado D, Cordoba J. A 1H nuclear magnetic resonance-based metabonomic approach for grading hepatic encephalopathy and monitoring the effects of therapeutic hypothermia in rats. Liver Int 2008, 28:1141-1148.
4. Chung PY, Sitrin MD, Te HS. Serum phosphorus levels predict clinical outcome in fulminant hepatic failure. Liver Transpl 2003, 9:248-253. 10.1053/jlts.2003.50053, 12619021.
5. MacQuillan GC, Seyam MS, Nightingale P, Neuberger JM, Murphy N. Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure. Liver Transpl 2005, 11:1073-1079. 10.1002/lt.20427, 16123967.
6. Shakil AO. Predicting the outcome of fulminant hepatic failure. Liver Transpl 2005, 11:1028-1030. 10.1002/lt.20478, 16123964.
7. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000, 6:163-169.
8. Schmidt LE, Larsen FS. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology 2007, 45:789-796. 10.1002/hep.21503, 17326205.
9. Barba I, de Leon G, Martin E, Cuevas A, Aquade S, Candell-Riera J, Barrabes JA, Garcia-Dorado D. Nuclear magnetic resonance-based metabolomics predicts exercise-induced ischemia in patients with suspected coronary artery disease. Magn Reson Med 2008, 60:27-32. 10.1002/mrm.21632, 18581408.
10. Serkova NJ, Gamito EJ, Jones RH, O'Donnell C, Brown JL, Green S, Sullivan H, Hedlund T, Crawford ED. The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions. Prostate 2008, 68:620-628. 10.1002/pros.20727, 18213632.
11. Gottschalk M, Ivanova G, Collins DM, Eustace A, O'Connor R, Brougham DF. Metabolomic studies of human lung carcinoma cell lines using in vitro 1H NMR of whole cells and cellular extracts. NMR Biomed 2008, 21:809-819. 10.1002/nbm.1258, 18470962.
12. Feng B, Wu S, Lv S, Liu F, Chen H, Yan X, Li Y, Dong F, Wei L. Metabolic profiling analysis of a d-galactosamine/lipopolysaccharide-induced mouse model of fulminant hepatic failure. J Proteome Res 2007, 6:2161-2167. 10.1021/pr0606326, 17497905.
13. Feng B, Wu S, Lv S, Fang J, Liu F, Li Y, Gao Y, Yan X, Dong F, Wei L. Dynamic metabonomic analysis of BALB/c mice with different outcomes after d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure. Liver Transpl 2008, 14:1620-1631. 10.1002/lt.21578, 18975270.
14. Pasikanti KK, Ho PC, Chan ECY. Development and validation of a gas chromatography/mass spectrometry metabonomic platform for the global profiling of urinary metabolites. Rapid Commun. Mass Spectrom 2008, 22:2984-2992.
15. Psihogios NG, Gazi IF, Elisaf MS, Seferiadis KI, Bairaktari ET. Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomics. NMR Biomed 2008, 21:195-207. 10.1002/nbm.1176, 17474139.
16. Bedair M, Sumner LW. Current and emerging mass spectrometry technologies for metabolomics. Trends Analyt Chem 2008, 27:238-250.
17. Li X, Cristina LQ. Advances in separation science applied to metabonomics. Electrophoresis 2008, 29:3724-3736. 10.1002/elps.200700851, 18850642.
18. Lu Y, A J, Wang G, Hao H, Huang Q, Yan B, Zha W, Gu S, Ren H, Zhang Y, Fan X, Zhang M, Hao K. Gas chromatography/time-of-flight mass spectrometry based metabonomic approach to differentiating hypertension- and age-related metabolic variation in spontaneously hypertensive rats. Rapid Commun Mass Spectrom 2008, 22:2882-2888. 10.1002/rcm.3670, 18720470.